Lester Chee Hao Leong
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Lester Chee Hao Leong has a total of 68 co-authors. Here are the top co-authors by number of shared publications:
- Geok Hoon Lim
Breast Department, KK Women’s and Children’s Hospital, Singapore 229899, Singapore
5 shared publications Puay Hoon Tan
Department of Anatomical Pathology Singapore General HospitalSinghealth Singapore Singapore
3 shared publicationsSze Yiun Teo
Department of Diagnostic & Interventional Imaging KK Women's and Children's Hospital Singapore Singapore
3 shared publications- Benita Kiat Tee Tan
Sengkang General Hospital
2 shared publications - Victoria Kai Lin Tay
Department of Diagnostic Radiology, Singapore General Hospital, Singapore (Singapore General Hospital, Singapore
2 shared publications Alwin Hwai Liang Loh
Department of Anatomical Pathology Singapore General HospitalSinghealth Singapore Singapore
1 shared publication
Latest Publications
- Open Access
- 11 October 2025
- Published by International Scientific Information, Inc. in American Journal of Case Reports
- Vol. 26, e948834
Atraumatic Breast Fat Necrosis Mimicking Malignancy in End-Stage Renal Disease: A Case Report
BACKGROUND Breast fat necrosis is a benign process in which fat undergoes aseptic saponification by blood and tissue lipase. It commonly occurs due to trauma or surgery and can mimic malignancy. We present an unusual case of atraumatic fat necrosis caused by extensive breast arterial calcifications in a woman with underlying diabetes mellitus and end-stage renal disease (ESRD). CASE REPORT A 61-year-old woman presented with a painful left breast lump for 3 days. Her medical history included hemodialysis-dependent ESRD, diabetic nephropathy, and poorly controlled tertiary hyperparathyroidism. Initial mammography revealed extensive arterial wall calcifications with no discrete mass, while ultrasound showed a poorly defined heterogeneous, predominantly hyperechoic mass. The lesion enlarged over 5 months, prompting surgical excision. Histopathological examination revealed extensive fat necrosis and widespread vascular calcification affecting variably sized vessels in a Mönckeberg sclerosis-like pattern. The calcification was severe enough to cause focal complete vascular occlusion with resultant infarction of breast fat. CONCLUSIONS This case highlights a rare and unusual presentation of atraumatic fat necrosis of the breast mimicking breast malignancy, both clinically and radiologically. Unlike the more common post-traumatic or post-surgical fat necrosis, this instance occurred in the absence of any known injury or intervention, making the diagnosis more challenging. It underscores the importance of considering fat necrosis in the differential diagnosis of breast masses in patients with ESRD, who often exhibit severe calcific vasculopathy, which can lead to tissue ischemia. Awareness of this potential mimic will be helpful in avoiding unnecessary interventions and guiding appropriate management.
- 11 October 2025
- Published by International Scientific Information, Inc. in American Journal of Case Reports
- Vol. 26, e948834
Open AccessAtraumatic Breast Fat Necrosis Mimicking Malignancy in End-Stage Renal Disease: A Case Report
BACKGROUND Breast fat necrosis is a benign process in which fat undergoes aseptic saponification by blood and tissue lipase. It commonly occurs due to trauma or surgery and can mimic malignancy. We present an unusual case of atraumatic fat necrosis caused by extensive breast arterial calcifications in a woman with underlying diabetes mellitus and end-stage renal disease (ESRD). CASE REPORT A 61-year-old woman presented with a painful left breast lump for 3 days. Her medical history included hemodialysis-dependent ESRD, diabetic nephropathy, and poorly controlled tertiary hyperparathyroidism. Initial mammography revealed extensive arterial wall calcifications with no discrete mass, while ultrasound showed a poorly defined heterogeneous, predominantly hyperechoic mass. The lesion enlarged over 5 months, prompting surgical excision. Histopathological examination revealed extensive fat necrosis and widespread vascular calcification affecting variably sized vessels in a Mönckeberg sclerosis-like pattern. The calcification was severe enough to cause focal complete vascular occlusion with resultant infarction of breast fat. CONCLUSIONS This case highlights a rare and unusual presentation of atraumatic fat necrosis of the breast mimicking breast malignancy, both clinically and radiologically. Unlike the more common post-traumatic or post-surgical fat necrosis, this instance occurred in the absence of any known injury or intervention, making the diagnosis more challenging. It underscores the importance of considering fat necrosis in the differential diagnosis of breast masses in patients with ESRD, who often exhibit severe calcific vasculopathy, which can lead to tissue ischemia. Awareness of this potential mimic will be helpful in avoiding unnecessary interventions and guiding appropriate management.
- Open Access
- 1 April 2025
- Published by AME Publishing Company in Gland Surgery
- Vol. 14 (4) , 781-784
Risking arm lymphedema in more than a hundred patients to benefit one patient—is it worth it?
Risking arm lymphedema in more than a hundred patients to benefit one patient—is it worth it?
- 1 April 2025
- Published by AME Publishing Company in Gland Surgery
- Vol. 14 (4) , 781-784
Open AccessRisking arm lymphedema in more than a hundred patients to benefit one patient—is it worth it?
Risking arm lymphedema in more than a hundred patients to benefit one patient—is it worth it?
- Open Access
- 1 January 2025
- Published by XMLink in Journal of the Korean Society of Radiology
- Vol. 86 (1) , 160-165
A Rare Normal Variant with an Unusual Presentation on a Male Mammogram: A Case Report
Tay VK, et al. J Korean Soc Radiol. 2025 Jan;86(1):160-165. https://doi.org/10.3348/jksr.2024.0054
- 1 January 2025
- Published by XMLink in Journal of the Korean Society of Radiology
- Vol. 86 (1) , 160-165
Open AccessA Rare Normal Variant with an Unusual Presentation on a Male Mammogram: A Case Report
Tay VK, et al. J Korean Soc Radiol. 2025 Jan;86(1):160-165. https://doi.org/10.3348/jksr.2024.0054
- 9 March 2022
- Published by Springer Nature in Breast Cancer Research and Treatment
- Vol. 193 (1) , 121-138
Multi-center evaluation of artificial intelligent imaging and clinical models for predicting neoadjuvant chemotherapy response in breast cancer
Background Neoadjuvant chemotherapy (NAC) plays an important role in the management of locally advanced breast cancer. It allows for downstaging of tumors, potentially allowing for breast conservation. NAC also allows for in-vivo testing of the tumors’ response to chemotherapy and provides important prognostic information. There are currently no clearly defined clinical models that incorporate imaging with clinical data to predict response to NAC. Thus, the aim of this work is to develop a predictive AI model based on routine CT imaging and clinical parameters to predict response to NAC. Methods The CT scans of 324 patients with NAC from multiple centers in Singapore were used in this study. Four different radiomics models were built for predicting pathological complete response (pCR): first two were based on textural features extracted from peri-tumoral and tumoral regions, the third model based on novel space-resolved radiomics which extract feature maps using voxel-based radiomics and the fourth model based on deep learning (DL). Clinical parameters were included to build a final prognostic model. Results The best performing models were based on space-resolved and DL approaches. Space-resolved radiomics improves the clinical AUCs of pCR prediction from 0.743 (0.650 to 0.831) to 0.775 (0.685 to 0.860) and our DL model improved it from 0.743 (0.650 to 0.831) to 0.772 (0.685 to 0.853). The tumoral radiomics model performs the worst with no improvement of the AUC from the clinical model. The peri-tumoral combined model gives moderate performance with an AUC of 0.765 (0.671 to 0.855). Conclusions Radiomics features extracted from diagnostic CT augment the predictive ability of pCR when combined with clinical features. The novel space-resolved radiomics and DL radiomics approaches outperformed conventional radiomics techniques.
- 9 March 2022
- Published by Springer Nature in Breast Cancer Research and Treatment
- Vol. 193 (1) , 121-138
Multi-center evaluation of artificial intelligent imaging and clinical models for predicting neoadjuvant chemotherapy response in breast cancer
Background Neoadjuvant chemotherapy (NAC) plays an important role in the management of locally advanced breast cancer. It allows for downstaging of tumors, potentially allowing for breast conservation. NAC also allows for in-vivo testing of the tumors’ response to chemotherapy and provides important prognostic information. There are currently no clearly defined clinical models that incorporate imaging with clinical data to predict response to NAC. Thus, the aim of this work is to develop a predictive AI model based on routine CT imaging and clinical parameters to predict response to NAC. Methods The CT scans of 324 patients with NAC from multiple centers in Singapore were used in this study. Four different radiomics models were built for predicting pathological complete response (pCR): first two were based on textural features extracted from peri-tumoral and tumoral regions, the third model based on novel space-resolved radiomics which extract feature maps using voxel-based radiomics and the fourth model based on deep learning (DL). Clinical parameters were included to build a final prognostic model. Results The best performing models were based on space-resolved and DL approaches. Space-resolved radiomics improves the clinical AUCs of pCR prediction from 0.743 (0.650 to 0.831) to 0.775 (0.685 to 0.860) and our DL model improved it from 0.743 (0.650 to 0.831) to 0.772 (0.685 to 0.853). The tumoral radiomics model performs the worst with no improvement of the AUC from the clinical model. The peri-tumoral combined model gives moderate performance with an AUC of 0.765 (0.671 to 0.855). Conclusions Radiomics features extracted from diagnostic CT augment the predictive ability of pCR when combined with clinical features. The novel space-resolved radiomics and DL radiomics approaches outperformed conventional radiomics techniques.
- 31 August 2021
- Published by Wiley in The Breast Journal
- Vol. 27 (12) , 883-886
Breast‐related extranodal Rosai‐Dorfman disease presenting as subcutaneous masses with thick hyperechoic rim, with review of the literature
Rosai-Dorfman disease (RDD) is a rare, idiopathic histiocytic proliferative disorder. We report two cases of RDD related to the breast which showed common distinctive imaging characteristics which can help facilitate accurate diagnosis and appropriate management.
- 31 August 2021
- Published by Wiley in The Breast Journal
- Vol. 27 (12) , 883-886
Breast‐related extranodal Rosai‐Dorfman disease presenting as subcutaneous masses with thick hyperechoic rim, with review of the literature
Rosai-Dorfman disease (RDD) is a rare, idiopathic histiocytic proliferative disorder. We report two cases of RDD related to the breast which showed common distinctive imaging characteristics which can help facilitate accurate diagnosis and appropriate management.
- 1 November 2020
- Published by Hindawi Limited in The Breast Journal
- Vol. 26 (11) , 2299-2301
Determining the factors affecting the visibilities of various clips in axillary nodes on magnetic resonance imaging (MRI)
Click on the article title to read more.
- 1 November 2020
- Published by Hindawi Limited in The Breast Journal
- Vol. 26 (11) , 2299-2301
Determining the factors affecting the visibilities of various clips in axillary nodes on magnetic resonance imaging (MRI)
Click on the article title to read more.
- Open Access
- 22 January 2020
- Published by Wiley in Cancer Medicine
- Vol. 9 (6) , 1978-1985
Initial results of a novel technique of clipped node localization in breast cancer patients postneoadjuvant chemotherapy: Skin Mark clipped Axillary nodes Removal Technique (SMART trial)
Purpose: Removal of clipped nodes can improve sentinel node biopsy accuracy in breast cancer patients post neoadjuvant chemotherapy (NACT). However, the current methods of clipped node localization have limitations. We evaluated the feasibility of a novel clipped node localization and removal technique by preoperative skin marking of clipped nodes and removal by the Skin Mark clipped Axillary nodes Removal Technique (SMART), with the secondary aim of assessing the ultrasound visibility of the various clips in the axillary nodes after NACT.Methods: Invasive breast cancer patients with histologically metastatic axillary nodes, going for NACT, and ≤3 sonographically abnormal axillary nodes were recruited. All abnormal nodes had clips inserted. Patients with M1 disease were excluded. Post‐NACT, patients underwent SMART and axillary lymph node dissection. Specimen radiography and pathological analyses were performed to confirm the clipped node presence. Success, complication rates of SMART, and ultrasound visibility of the various clips were assessed.Results: Twenty‐five clipped nodes in 14 patients underwent SMART without complications. The UltraCor Twirl, hydroMARK, UltraClip Dual Trigger, and UltraClip were removed in 13/13 (100%), 7/9 (77.8%), 1/2 (50.0%), and 0/1 (0%), respectively (P = .0103) with UltraCor Twirl having the best ultrasound visibility and removal rate. Removal of three clipped nodes in the same patient (P = .0010) and deeply seated clipped nodes (P = .0167) were associated with SMART failure.Conclusion: Skin Mark clipped Axillary nodes Removal Technique is feasible for removing clipped nodes post‐NACT, with 100% observed success rate, using the UltraCor Twirl marker in patients with <3 not deeply seated clipped nodes. Larger studies are needed for validation.
- 22 January 2020
- Published by Wiley in Cancer Medicine
- Vol. 9 (6) , 1978-1985
Open AccessInitial results of a novel technique of clipped node localization in breast cancer patients postneoadjuvant chemotherapy: Skin Mark clipped Axillary nodes Removal Technique (SMART trial)
Purpose: Removal of clipped nodes can improve sentinel node biopsy accuracy in breast cancer patients post neoadjuvant chemotherapy (NACT). However, the current methods of clipped node localization have limitations. We evaluated the feasibility of a novel clipped node localization and removal technique by preoperative skin marking of clipped nodes and removal by the Skin Mark clipped Axillary nodes Removal Technique (SMART), with the secondary aim of assessing the ultrasound visibility of the various clips in the axillary nodes after NACT.Methods: Invasive breast cancer patients with histologically metastatic axillary nodes, going for NACT, and ≤3 sonographically abnormal axillary nodes were recruited. All abnormal nodes had clips inserted. Patients with M1 disease were excluded. Post‐NACT, patients underwent SMART and axillary lymph node dissection. Specimen radiography and pathological analyses were performed to confirm the clipped node presence. Success, complication rates of SMART, and ultrasound visibility of the various clips were assessed.Results: Twenty‐five clipped nodes in 14 patients underwent SMART without complications. The UltraCor Twirl, hydroMARK, UltraClip Dual Trigger, and UltraClip were removed in 13/13 (100%), 7/9 (77.8%), 1/2 (50.0%), and 0/1 (0%), respectively (P = .0103) with UltraCor Twirl having the best ultrasound visibility and removal rate. Removal of three clipped nodes in the same patient (P = .0010) and deeply seated clipped nodes (P = .0167) were associated with SMART failure.Conclusion: Skin Mark clipped Axillary nodes Removal Technique is feasible for removing clipped nodes post‐NACT, with 100% observed success rate, using the UltraCor Twirl marker in patients with <3 not deeply seated clipped nodes. Larger studies are needed for validation.
- 2 December 2019
- Published by Hindawi Limited in The Breast Journal
- Vol. 26 (5) , 1025-1027
Extensive Florid Lobular carcinoma in situ presenting as a large breast mass requiring a mastectomy
Click on the article title to read more.
- 2 December 2019
- Published by Hindawi Limited in The Breast Journal
- Vol. 26 (5) , 1025-1027
Extensive Florid Lobular carcinoma in situ presenting as a large breast mass requiring a mastectomy
Click on the article title to read more.
- 28 September 2019
- Published by Hindawi Limited in The Breast Journal
- Vol. 26 (4) , 775-777
Myoepithelial hyperplasia: A rare mimic of breast cancer on 18 F‐FDG PET/CT
Click on the article title to read more.
- 28 September 2019
- Published by Hindawi Limited in The Breast Journal
- Vol. 26 (4) , 775-777
Myoepithelial hyperplasia: A rare mimic of breast cancer on 18 F‐FDG PET/CT
Click on the article title to read more.
- 8 September 2019
- Published by Wiley in The Breast Journal
- Vol. 26 (2) , 162-167
Evaluating the preoperative breast cancer characteristics affecting the accuracy of axillary ultrasound staging
We evaluate the preoperative breast cancer (BC) characteristics that affect the diagnostic accuracy of axillary ultrasound (US) and determine the reliability of US in the different subgroups of BC patients. Axillary US assessments in women with invasive BC diagnosed between 2009 and 2016 in a single institution were retrospectively reviewed. The diagnostic accuracy of axillary US was obtained using surgical nodal histology as the gold standard. Preoperative breast tumor sonographic and histological factors affecting axillary US diagnostic accuracy were examined. Of the 605 newly diagnosed invasive BC cases reviewed, 251 (41.5%) had nodal metastases. Axillary US sensitivity was 75.7%, specificity 92.9%, positive predictive value 88.4%, negative predictive value 84.4%, and false‐negative rate 24.3%. Lower US sensitivity was seen with invasive lobular cancer (ILC) (P = .043), grade I/II, (P = .021), unifocal (P = .039), and smaller tumors (P < .001). US specificity was lower in grade III (P < .001), estrogen receptor (ER)‐negative (P < .001), progesterone receptor (PR)‐negative (P = .004), HER2‐positive (P = .015), triple‐negative (P = .001), and larger breast tumors (P < .001). US has moderate sensitivity and good specificity in detecting metastatic axillary lymph nodes. Based on preoperative cancer characteristics, US was less sensitive for nodal metastases from ILC, unifocal, lower grade, and smaller breast tumors. It was also less specific in grade III, ER‐negative, PR‐negative, HER2‐positive, triple‐negative, and larger breast tumors. Caution is suggested in interpreting the US axillary findings of patients with these preoperative tumor features.
- 8 September 2019
- Published by Wiley in The Breast Journal
- Vol. 26 (2) , 162-167
Evaluating the preoperative breast cancer characteristics affecting the accuracy of axillary ultrasound staging
We evaluate the preoperative breast cancer (BC) characteristics that affect the diagnostic accuracy of axillary ultrasound (US) and determine the reliability of US in the different subgroups of BC patients. Axillary US assessments in women with invasive BC diagnosed between 2009 and 2016 in a single institution were retrospectively reviewed. The diagnostic accuracy of axillary US was obtained using surgical nodal histology as the gold standard. Preoperative breast tumor sonographic and histological factors affecting axillary US diagnostic accuracy were examined. Of the 605 newly diagnosed invasive BC cases reviewed, 251 (41.5%) had nodal metastases. Axillary US sensitivity was 75.7%, specificity 92.9%, positive predictive value 88.4%, negative predictive value 84.4%, and false‐negative rate 24.3%. Lower US sensitivity was seen with invasive lobular cancer (ILC) (P = .043), grade I/II, (P = .021), unifocal (P = .039), and smaller tumors (P < .001). US specificity was lower in grade III (P < .001), estrogen receptor (ER)‐negative (P < .001), progesterone receptor (PR)‐negative (P = .004), HER2‐positive (P = .015), triple‐negative (P = .001), and larger breast tumors (P < .001). US has moderate sensitivity and good specificity in detecting metastatic axillary lymph nodes. Based on preoperative cancer characteristics, US was less sensitive for nodal metastases from ILC, unifocal, lower grade, and smaller breast tumors. It was also less specific in grade III, ER‐negative, PR‐negative, HER2‐positive, triple‐negative, and larger breast tumors. Caution is suggested in interpreting the US axillary findings of patients with these preoperative tumor features.